Search

everythinglearnresearchcommunity

for

Search:↓

Gene therapy in mice increased lifespan and improved health without causing cancer.

No cure exists for alopecia areata, and treatments are personalized.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

The document suggests a bacteria plays a significant role in acne rosacea and that white hair can regain color after transplant, meriting more research on reversing grey hair.

Stem cell therapy shows promise in improving burn wound healing.

Tph cells are linked to the severity of systemic lupus erythematosus.

Targeting specific T cells may help treat alopecia areata.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Nanoparticles can deliver vaccines through hair follicles, triggering immune responses and providing protection.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Tiny vesicles from stem cells could be a new treatment for healing wounds.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Extracellular vesicles show promise for wound healing, but more research is needed to improve their stability and production.

ADSC-derived extracellular vesicles show promise for skin and hair regeneration and wound healing.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

Dandruff might be caused by changes in how hair follicles naturally release oils and an immune response to this imbalance.

Human skin has less GDNF and its receptor with age.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Microneedles with extracellular vesicles show promise for treating various conditions with targeted delivery.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Immune activities and specific genes are important in male pattern baldness.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.